secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prime Medicine, Inc. (PRME)
CIK:        0001894562
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001628280-23-022447
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Prime Medicine elects Kelly and Schenkein to board, ratifies PwC as auditor
---------------------------------------------------------------------------

- Michael Kelly elected Class I director with 64.5M for, 1.3M withheld; David Schenkein with 62.0M for, 3.7M withheld.
- Broker non-votes on director election totaled 1,517,331.
- PricewaterhouseCoopers LLP ratified as independent auditor for FY2023 with 67.3M for, 6.3K against, 11.5K abstentions.
- Annual meeting held June 14, 2023; all proposals approved by stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894562/000162828023022447/0001628280-23-022447-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894562/000162828023022447/prme-20230614.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-022447

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer